sobig personal page - To The Moon

sobig

sobig

No personal profile

51Follow

8Followers

0Topic

0Badge

2021-09-21

$OVERSEA-CHINESE BANKING CORP(O39.SI)$buy more ?

2021-09-11

$Apple(AAPL)$dropped liao

2021-09-10

$OVERSEA-CHINESE BANKING CORP(O39.SI)$up up up. $12

2021-09-10

$STI ETF(ES3.SI)$Right choice to buy more.

2021-09-02

$FRASERS PROPERTY LIMITED(TQ5.SI)$Suisui not moving

2021-08-28

Good

What Is Going On With Jumia Stock?

2021-08-28

++

U.S. resumes supply of Lilly's COVID-19 antibody combo to some states

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4093095324779850","uuid":"4093095324779850","gmtCreate":1630065334641,"gmtModify":1630069826741,"name":"sobig","pinyin":"sobig","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":51,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":860705532,"gmtCreate":1632207273726,"gmtModify":1676530725424,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>buy more ?&nbsp;","listText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>buy more ?&nbsp;","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$buy more ?","images":[{"img":"https://static.tigerbbs.com/47f9a367926964e1aeed3c51244731df","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860705532","isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881639434,"gmtCreate":1631329243128,"gmtModify":1676530530059,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>dropped liao","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>dropped liao","text":"$Apple(AAPL)$dropped liao","images":[{"img":"https://static.tigerbbs.com/24b1d6aa4085319a626c2edb727766cb","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881639434","isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881069313,"gmtCreate":1631281741832,"gmtModify":1676530518249,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>up up up. $12","listText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>up up up. $12","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$up up up. $12","images":[{"img":"https://static.tigerbbs.com/6cd86cde4e206ec0f976ebe992322628","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881069313","isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881085519,"gmtCreate":1631281625031,"gmtModify":1676530518158,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>Right choice to buy more.","listText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>Right choice to buy more.","text":"$STI ETF(ES3.SI)$Right choice to buy more.","images":[{"img":"https://static.tigerbbs.com/4ed5bc382824973f5ad2ddbf2b172372","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881085519","isVote":1,"tweetType":1,"viewCount":429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":812832025,"gmtCreate":1630571747167,"gmtModify":1676530343723,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TQ5.SI\">$FRASERS PROPERTY LIMITED(TQ5.SI)$</a>Suisui not moving","listText":"<a href=\"https://laohu8.com/S/TQ5.SI\">$FRASERS PROPERTY LIMITED(TQ5.SI)$</a>Suisui not moving","text":"$FRASERS PROPERTY LIMITED(TQ5.SI)$Suisui not moving","images":[{"img":"https://static.tigerbbs.com/0a84b36fb54f64d9700674814ee1b6be","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812832025","isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":813920556,"gmtCreate":1630122765675,"gmtModify":1676530230481,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813920556","repostId":"2162358024","repostType":4,"repost":{"id":"2162358024","kind":"highlight","pubTimestamp":1630077895,"share":"https://ttm.financial/m/news/2162358024?lang=&edition=fundamental","pubTime":"2021-08-27 23:24","market":"us","language":"en","title":"What Is Going On With Jumia Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2162358024","media":"Motley Fool","summary":"The African e-commerce site offers massive long-term potential. But did it enter the market too soon?","content":"<p>E-commerce is one of the most pivotal retail megatrends in our lifetime, and the transformation is far from complete. While e-commerce platforms like<b> <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a></b> and <b><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> Group Holding</b> are solidifying their dominance in established markets, <b><a href=\"https://laohu8.com/S/JMIA\">Jumia Technologies AG</a> </b>(NYSE:JMIA) aims to build a first-mover advantage in one of the last frontiers for widespread online shopping: Africa. </p>\n<p>Is it time to bet on Jumia or sit on the sidelines until the market becomes more developed?</p>\n<h2>A potential opportunity</h2>\n<p>It is unclear how fast Africa's e-commerce market is growing or how much it is worth from a business perspective, but it has potential. First, Africa has a massive population of 1.4 billion, with an average age of 20. Second, and more important, internet use is surging, which drives e-commerce adoption.&nbsp;</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640851%2Fgettyimages-1327790012.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b><a href=\"https://laohu8.com/S/CSCO\">Cisco</a></b> estimates that internet traffic in the Middle East and Africa grew at a compound annual rate of 42% between 2016 and 2021. And massive investments in infrastructure could help the sector keep its momentum in the coming decades. <b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) is installing a subsea cable called 2Africa that will provide almost triple the network capacity of all subsea cables currently serving the continent by 2023. <b><a href=\"https://laohu8.com/S/GOOG\">Alphabet</a></b>'s (NASDAQ:GOOG)(NASDAQ:GOOGL) Google is undertaking a similar project called Equiano, expected to complete the first phase this year.</p>\n<p>But internet penetration doesn't guarantee e-commerce adoption. And Jumia's challenge will be to overcome Africa's hard infrastructure challenges (roads, bridges, and the like) while encouraging the adoption of a brand new way of shopping for many people. So far, the results aren't encouraging.&nbsp;</p>\n<h2>Growing at a snail's pace</h2>\n<p>Jumia's first-quarter revenue increased by a measly 4.6% year over year to $40.2 million. And that wasn't even driven by its core third-party e-commerce marketplace, where annual active customers only grew just 3.3% to 7 million. Marketing and advertising (up 18%) was the company's best-performing segment in the quarter, but this opportunity has a very limited runway for expansion with user growth so slow.&nbsp;</p>\n<p>To make matters worse, the total value of goods sold on Jumia (gross merchandise value) declined by 11% to 223.5 million as consumers shifted from high-value items like phones to everyday items like toiletries. </p>\n<p>This slowdown is alarming because Jumia is still far from profitable and would benefit from more scale to cover its overhead. <a href=\"https://laohu8.com/S/BGC\">General</a> and administrative costs totaled a whopping $34.2 million (85% of revenue) in the second quarter, and its operating loss increased 25% year over year to $51.6 million in the period.&nbsp;</p>\n<p>That said, management is taking steps to turn things around. Jumia is boosting its investment in marketing and technology and has begun testing micro fulfillment centers in highly populated areas to help deliver groceries. It is also developing social commerce features like user-generated content (video/picture uploads). But it could take years for these efforts to trickle down to the company's bottom line, and that's a long wait for shareholders.</p>\n<h2>Jumia is not a buy (yet)</h2>\n<p>While Jumia faces massive challenges, I don't think it's a write-off. The African e-commerce market has potential, but it isn't mature yet. And Jumia might have arrived too early to create a viable business in the niche.</p>\n<p> But the company has accumulated logistics infrastructure, along with user data and experience that could be valuable in the right hands. Jumia stock is not a slam-dunk buy right now, but it is certainly worth watching.&nbsp;</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going On With Jumia Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going On With Jumia Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 23:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/what-is-going-on-with-jumia-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>E-commerce is one of the most pivotal retail megatrends in our lifetime, and the transformation is far from complete. While e-commerce platforms like Amazon.com and Alibaba Group Holding are ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/what-is-going-on-with-jumia-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JMIA":"Jumia Technologies AG"},"source_url":"https://www.fool.com/investing/2021/08/27/what-is-going-on-with-jumia-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162358024","content_text":"E-commerce is one of the most pivotal retail megatrends in our lifetime, and the transformation is far from complete. While e-commerce platforms like Amazon.com and Alibaba Group Holding are solidifying their dominance in established markets, Jumia Technologies AG (NYSE:JMIA) aims to build a first-mover advantage in one of the last frontiers for widespread online shopping: Africa. \nIs it time to bet on Jumia or sit on the sidelines until the market becomes more developed?\nA potential opportunity\nIt is unclear how fast Africa's e-commerce market is growing or how much it is worth from a business perspective, but it has potential. First, Africa has a massive population of 1.4 billion, with an average age of 20. Second, and more important, internet use is surging, which drives e-commerce adoption. \n\nImage source: Getty Images.\nCisco estimates that internet traffic in the Middle East and Africa grew at a compound annual rate of 42% between 2016 and 2021. And massive investments in infrastructure could help the sector keep its momentum in the coming decades. Facebook (NASDAQ:FB) is installing a subsea cable called 2Africa that will provide almost triple the network capacity of all subsea cables currently serving the continent by 2023. Alphabet's (NASDAQ:GOOG)(NASDAQ:GOOGL) Google is undertaking a similar project called Equiano, expected to complete the first phase this year.\nBut internet penetration doesn't guarantee e-commerce adoption. And Jumia's challenge will be to overcome Africa's hard infrastructure challenges (roads, bridges, and the like) while encouraging the adoption of a brand new way of shopping for many people. So far, the results aren't encouraging. \nGrowing at a snail's pace\nJumia's first-quarter revenue increased by a measly 4.6% year over year to $40.2 million. And that wasn't even driven by its core third-party e-commerce marketplace, where annual active customers only grew just 3.3% to 7 million. Marketing and advertising (up 18%) was the company's best-performing segment in the quarter, but this opportunity has a very limited runway for expansion with user growth so slow. \nTo make matters worse, the total value of goods sold on Jumia (gross merchandise value) declined by 11% to 223.5 million as consumers shifted from high-value items like phones to everyday items like toiletries. \nThis slowdown is alarming because Jumia is still far from profitable and would benefit from more scale to cover its overhead. General and administrative costs totaled a whopping $34.2 million (85% of revenue) in the second quarter, and its operating loss increased 25% year over year to $51.6 million in the period. \nThat said, management is taking steps to turn things around. Jumia is boosting its investment in marketing and technology and has begun testing micro fulfillment centers in highly populated areas to help deliver groceries. It is also developing social commerce features like user-generated content (video/picture uploads). But it could take years for these efforts to trickle down to the company's bottom line, and that's a long wait for shareholders.\nJumia is not a buy (yet)\nWhile Jumia faces massive challenges, I don't think it's a write-off. The African e-commerce market has potential, but it isn't mature yet. And Jumia might have arrived too early to create a viable business in the niche.\n But the company has accumulated logistics infrastructure, along with user data and experience that could be valuable in the right hands. Jumia stock is not a slam-dunk buy right now, but it is certainly worth watching.","news_type":1},"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813920649,"gmtCreate":1630122739781,"gmtModify":1676530230482,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"++","listText":"++","text":"++","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813920649","repostId":"2162707824","repostType":4,"repost":{"id":"2162707824","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630104635,"share":"https://ttm.financial/m/news/2162707824?lang=&edition=fundamental","pubTime":"2021-08-28 06:50","market":"us","language":"en","title":"U.S. resumes supply of Lilly's COVID-19 antibody combo to some states","url":"https://stock-news.laohu8.com/highlight/detail?id=2162707824","media":"Reuters","summary":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID","content":"<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. resumes supply of Lilly's COVID-19 antibody combo to some states</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. resumes supply of Lilly's COVID-19 antibody combo to some states\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-28 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","VIR":"Vir Biotechnology, Inc.","REGN":"再生元制药公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162707824","content_text":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.\nThe Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.\nWith the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said\nBased on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.\nThe department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.\nThe supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.\nRegeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's\nsotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.\nBamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.","news_type":1},"isVote":1,"tweetType":1,"viewCount":253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":860705532,"gmtCreate":1632207273726,"gmtModify":1676530725424,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>buy more ?&nbsp;","listText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>buy more ?&nbsp;","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$buy more ?","images":[{"img":"https://static.tigerbbs.com/47f9a367926964e1aeed3c51244731df","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860705532","isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":812832025,"gmtCreate":1630571747167,"gmtModify":1676530343723,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TQ5.SI\">$FRASERS PROPERTY LIMITED(TQ5.SI)$</a>Suisui not moving","listText":"<a href=\"https://laohu8.com/S/TQ5.SI\">$FRASERS PROPERTY LIMITED(TQ5.SI)$</a>Suisui not moving","text":"$FRASERS PROPERTY LIMITED(TQ5.SI)$Suisui not moving","images":[{"img":"https://static.tigerbbs.com/0a84b36fb54f64d9700674814ee1b6be","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812832025","isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881069313,"gmtCreate":1631281741832,"gmtModify":1676530518249,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>up up up. $12","listText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>up up up. $12","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$up up up. $12","images":[{"img":"https://static.tigerbbs.com/6cd86cde4e206ec0f976ebe992322628","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881069313","isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881085519,"gmtCreate":1631281625031,"gmtModify":1676530518158,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>Right choice to buy more.","listText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>Right choice to buy more.","text":"$STI ETF(ES3.SI)$Right choice to buy more.","images":[{"img":"https://static.tigerbbs.com/4ed5bc382824973f5ad2ddbf2b172372","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881085519","isVote":1,"tweetType":1,"viewCount":429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":813920556,"gmtCreate":1630122765675,"gmtModify":1676530230481,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813920556","repostId":"2162358024","repostType":4,"repost":{"id":"2162358024","kind":"highlight","pubTimestamp":1630077895,"share":"https://ttm.financial/m/news/2162358024?lang=&edition=fundamental","pubTime":"2021-08-27 23:24","market":"us","language":"en","title":"What Is Going On With Jumia Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2162358024","media":"Motley Fool","summary":"The African e-commerce site offers massive long-term potential. But did it enter the market too soon?","content":"<p>E-commerce is one of the most pivotal retail megatrends in our lifetime, and the transformation is far from complete. While e-commerce platforms like<b> <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a></b> and <b><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> Group Holding</b> are solidifying their dominance in established markets, <b><a href=\"https://laohu8.com/S/JMIA\">Jumia Technologies AG</a> </b>(NYSE:JMIA) aims to build a first-mover advantage in one of the last frontiers for widespread online shopping: Africa. </p>\n<p>Is it time to bet on Jumia or sit on the sidelines until the market becomes more developed?</p>\n<h2>A potential opportunity</h2>\n<p>It is unclear how fast Africa's e-commerce market is growing or how much it is worth from a business perspective, but it has potential. First, Africa has a massive population of 1.4 billion, with an average age of 20. Second, and more important, internet use is surging, which drives e-commerce adoption.&nbsp;</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640851%2Fgettyimages-1327790012.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b><a href=\"https://laohu8.com/S/CSCO\">Cisco</a></b> estimates that internet traffic in the Middle East and Africa grew at a compound annual rate of 42% between 2016 and 2021. And massive investments in infrastructure could help the sector keep its momentum in the coming decades. <b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) is installing a subsea cable called 2Africa that will provide almost triple the network capacity of all subsea cables currently serving the continent by 2023. <b><a href=\"https://laohu8.com/S/GOOG\">Alphabet</a></b>'s (NASDAQ:GOOG)(NASDAQ:GOOGL) Google is undertaking a similar project called Equiano, expected to complete the first phase this year.</p>\n<p>But internet penetration doesn't guarantee e-commerce adoption. And Jumia's challenge will be to overcome Africa's hard infrastructure challenges (roads, bridges, and the like) while encouraging the adoption of a brand new way of shopping for many people. So far, the results aren't encouraging.&nbsp;</p>\n<h2>Growing at a snail's pace</h2>\n<p>Jumia's first-quarter revenue increased by a measly 4.6% year over year to $40.2 million. And that wasn't even driven by its core third-party e-commerce marketplace, where annual active customers only grew just 3.3% to 7 million. Marketing and advertising (up 18%) was the company's best-performing segment in the quarter, but this opportunity has a very limited runway for expansion with user growth so slow.&nbsp;</p>\n<p>To make matters worse, the total value of goods sold on Jumia (gross merchandise value) declined by 11% to 223.5 million as consumers shifted from high-value items like phones to everyday items like toiletries. </p>\n<p>This slowdown is alarming because Jumia is still far from profitable and would benefit from more scale to cover its overhead. <a href=\"https://laohu8.com/S/BGC\">General</a> and administrative costs totaled a whopping $34.2 million (85% of revenue) in the second quarter, and its operating loss increased 25% year over year to $51.6 million in the period.&nbsp;</p>\n<p>That said, management is taking steps to turn things around. Jumia is boosting its investment in marketing and technology and has begun testing micro fulfillment centers in highly populated areas to help deliver groceries. It is also developing social commerce features like user-generated content (video/picture uploads). But it could take years for these efforts to trickle down to the company's bottom line, and that's a long wait for shareholders.</p>\n<h2>Jumia is not a buy (yet)</h2>\n<p>While Jumia faces massive challenges, I don't think it's a write-off. The African e-commerce market has potential, but it isn't mature yet. And Jumia might have arrived too early to create a viable business in the niche.</p>\n<p> But the company has accumulated logistics infrastructure, along with user data and experience that could be valuable in the right hands. Jumia stock is not a slam-dunk buy right now, but it is certainly worth watching.&nbsp;</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going On With Jumia Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going On With Jumia Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 23:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/what-is-going-on-with-jumia-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>E-commerce is one of the most pivotal retail megatrends in our lifetime, and the transformation is far from complete. While e-commerce platforms like Amazon.com and Alibaba Group Holding are ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/what-is-going-on-with-jumia-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JMIA":"Jumia Technologies AG"},"source_url":"https://www.fool.com/investing/2021/08/27/what-is-going-on-with-jumia-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162358024","content_text":"E-commerce is one of the most pivotal retail megatrends in our lifetime, and the transformation is far from complete. While e-commerce platforms like Amazon.com and Alibaba Group Holding are solidifying their dominance in established markets, Jumia Technologies AG (NYSE:JMIA) aims to build a first-mover advantage in one of the last frontiers for widespread online shopping: Africa. \nIs it time to bet on Jumia or sit on the sidelines until the market becomes more developed?\nA potential opportunity\nIt is unclear how fast Africa's e-commerce market is growing or how much it is worth from a business perspective, but it has potential. First, Africa has a massive population of 1.4 billion, with an average age of 20. Second, and more important, internet use is surging, which drives e-commerce adoption. \n\nImage source: Getty Images.\nCisco estimates that internet traffic in the Middle East and Africa grew at a compound annual rate of 42% between 2016 and 2021. And massive investments in infrastructure could help the sector keep its momentum in the coming decades. Facebook (NASDAQ:FB) is installing a subsea cable called 2Africa that will provide almost triple the network capacity of all subsea cables currently serving the continent by 2023. Alphabet's (NASDAQ:GOOG)(NASDAQ:GOOGL) Google is undertaking a similar project called Equiano, expected to complete the first phase this year.\nBut internet penetration doesn't guarantee e-commerce adoption. And Jumia's challenge will be to overcome Africa's hard infrastructure challenges (roads, bridges, and the like) while encouraging the adoption of a brand new way of shopping for many people. So far, the results aren't encouraging. \nGrowing at a snail's pace\nJumia's first-quarter revenue increased by a measly 4.6% year over year to $40.2 million. And that wasn't even driven by its core third-party e-commerce marketplace, where annual active customers only grew just 3.3% to 7 million. Marketing and advertising (up 18%) was the company's best-performing segment in the quarter, but this opportunity has a very limited runway for expansion with user growth so slow. \nTo make matters worse, the total value of goods sold on Jumia (gross merchandise value) declined by 11% to 223.5 million as consumers shifted from high-value items like phones to everyday items like toiletries. \nThis slowdown is alarming because Jumia is still far from profitable and would benefit from more scale to cover its overhead. General and administrative costs totaled a whopping $34.2 million (85% of revenue) in the second quarter, and its operating loss increased 25% year over year to $51.6 million in the period. \nThat said, management is taking steps to turn things around. Jumia is boosting its investment in marketing and technology and has begun testing micro fulfillment centers in highly populated areas to help deliver groceries. It is also developing social commerce features like user-generated content (video/picture uploads). But it could take years for these efforts to trickle down to the company's bottom line, and that's a long wait for shareholders.\nJumia is not a buy (yet)\nWhile Jumia faces massive challenges, I don't think it's a write-off. The African e-commerce market has potential, but it isn't mature yet. And Jumia might have arrived too early to create a viable business in the niche.\n But the company has accumulated logistics infrastructure, along with user data and experience that could be valuable in the right hands. Jumia stock is not a slam-dunk buy right now, but it is certainly worth watching.","news_type":1},"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881639434,"gmtCreate":1631329243128,"gmtModify":1676530530059,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>dropped liao","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>dropped liao","text":"$Apple(AAPL)$dropped liao","images":[{"img":"https://static.tigerbbs.com/24b1d6aa4085319a626c2edb727766cb","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881639434","isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":813920649,"gmtCreate":1630122739781,"gmtModify":1676530230482,"author":{"id":"4093095324779850","authorId":"4093095324779850","name":"sobig","avatar":"https://static.tigerbbs.com/ef3ef3a0108dcf6280d42f1a667e321c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093095324779850","authorIdStr":"4093095324779850"},"themes":[],"htmlText":"++","listText":"++","text":"++","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813920649","repostId":"2162707824","repostType":4,"repost":{"id":"2162707824","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630104635,"share":"https://ttm.financial/m/news/2162707824?lang=&edition=fundamental","pubTime":"2021-08-28 06:50","market":"us","language":"en","title":"U.S. resumes supply of Lilly's COVID-19 antibody combo to some states","url":"https://stock-news.laohu8.com/highlight/detail?id=2162707824","media":"Reuters","summary":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID","content":"<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. resumes supply of Lilly's COVID-19 antibody combo to some states</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. resumes supply of Lilly's COVID-19 antibody combo to some states\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-28 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","VIR":"Vir Biotechnology, Inc.","REGN":"再生元制药公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162707824","content_text":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.\nThe Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.\nWith the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said\nBased on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.\nThe department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.\nThe supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.\nRegeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's\nsotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.\nBamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.","news_type":1},"isVote":1,"tweetType":1,"viewCount":253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}